New paper by Dr. Orlanda Harvey

Congratulations to Dr. Orlanda Harvey and Dr. Margarete Parrish both in the Department of Sociology and Social Work on the acceptance of their latest paper ‘Mixed-methods research on androgen abuse – a review’ by the journal Current Opinion in Endocrinology & Diabetes [1]. Orlanda was invited to write this review on the basis of her PhD research project.  Her PhD used a mixed-methods approach with people using un-prescribe /recreational Anabolic Androgenic Steroid (AAS) in several high-income countries including the UK.  Anabolic Androgenic Steroids are synthetic drugs mimicking male sex hormones, especially testosterone, and are often used for their anabolic effects, for example, increasing muscle and strength.  This PhD study resulted in several high-quality academic publications [2-4] as well as a feature article in HED Matters under the title ‘ECR Spotlight: From Social Work to Studying Steroids’ [5].
Congratulations!
Prof. Edwin van Teijlingen
CMMPH
References:
  1. Harvey, O., van Teijlingen, E., Parrish, M. (2022) Mixed-methods research on androgen abuse – a review, Current Opinion in Endocrinology & Diabetes (accepted)
  2. Harvey, O., Parrish, M., van Teijlingen, E, Trenoweth, S. (2021) Libido as a reason to use non-prescribed Anabolic Androgenic Steroids, Drugs: Education, Prevention & Policy 29:3,276-288,DOI10.1080/09687637.2021.1882940
  3. Harvey, O., Keen, S., Parrish, M., van Teijlingen, E. (2019) Support for people who use Anabolic Androgenic Steroids: A Systematic Literature Review into what they want and what they access. BMC Public Health 19: 1024 https://doi.org/10.1186/s12889-019-7288-x https://rdcu.be/bMFon
  4. Harvey, O., Parrish, M., van Teijlingen, E., Trenoweth, S. (2020) Support for non-prescribed Anabolic Androgenic Steroids users: A qualitative exploration of their needs Drugs: Education, Prevention & Policy 27:5, 377-386. DOI 10.1080/09687637.2019.1705763
  5. Harvey, O., (2019) ECR Spotlight: From Social Work to Studying SteroidsHED Matters 2(2):16-19.